The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19

Página do item simplificado
dc.contributor.authorPereira, Marcos
dc.contributor.authorPaixão, Enny
dc.contributor.authorTrajman, Anete
dc.contributor.authorSouza, Ramon Andrade de
dc.contributor.authorNatividade, Marcio Santos da
dc.contributor.authorPescarini, Julia M.
dc.contributor.authorPereira, Susan Martins
dc.contributor.authorBarreto, Florisneide Rodrigues
dc.contributor.authorXimenes, Ricardo
dc.contributor.authorDalcomo, Margareth
dc.contributor.authorIchihara, Maria Yury
dc.contributor.authorNunes, Ceuci
dc.contributor.authorBarral-Netto, Manoel
dc.contributor.authorBarreto, Maurício L.
dc.date.accessioned2024-12-16T12:10:41Z
dc.date.available2024-12-16T12:10:41Z
dc.date.issued2020
dc.description.abstractBacillus Calmette-Guérin (BCG) vaccination is routine and near-universal in many low- and middle-income countries (LMIC). It has been suggested that BCG can have a protective effect on COVID-19 morbidity and mortality. This commentary discusses the limitations of the evidence around BCG and COVID-19. We argue that higher-quality evidence is necessary to understand the protective effect of the BCG vaccine from existing, secondary data, while we await results from clinical trials currently conducted in different settings.
dc.identifier.citationPereira M, Paixão E, Trajman A, de Souza RA, da Natividade MS, Pescarini JM, Pereira SM, Barreto FR, Ximenes R, Dalcomo M, Ichihara MY, Nunes C, Barral-Netto M, Barreto ML. The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19. Respir Res. 2020 Jul 11;21(1):178. doi: 10.1186/s12931-020-01439-4.
dc.identifier.otherDOI: 10.1186/s12931-020-01439-4
dc.identifier.urihttps://dspace.inc.saude.gov.br/handle/123456789/724
dc.language.isoen
dc.publisherRespiratory Research
dc.subjectBCG Vaccine / immunology*en
dc.subjectBCG Vaccine / therapeutic use*en
dc.subjectCOVID-19en
dc.subjectClinical Trials as Topicen
dc.subjectCoronavirus Infections / mortalityen
dc.subjectCoronavirus Infections / prevention & control*en
dc.subjectCoronavirus Infections / therapy*en
dc.subjectCost-Benefit Analysisen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectMaleen
dc.subjectNeeds Assessmenten
dc.subjectPandemics / prevention & control*en
dc.subjectPneumonia, Viral / mortalityen
dc.subjectPneumonia, Viral / prevention & control*en
dc.subjectPneumonia, Viral / therapy*en
dc.subjectPovertyen
dc.subjectPrimary Prevention / methodsen
dc.subjectQuality Control*en
dc.subjectRoleen
dc.subjectSocioeconomic Factorsen
dc.subjectSurvival Analysisen
dc.subjectVaccination / methodsen
dc.subjectVaccination / statistics & numerical data.en
dc.titleThe need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19
dc.typeArticle
Arquivos
Original bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.alt
Nome:
Pereira M et al_Respiratory Research.pdf
Tamanho:
257.12 KB
Formato:
Adobe Portable Document Format
Descrição:
Baixar
License bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.placeholder
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed to upon submission
Descrição:
Baixar
Coleções
Produção Docente